OnKure Therapeutics, Inc. (OKUR) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 197.48M | 60.84M | 71.53M | 84.55M | 98.17M | 113M | 77M | 23.8M | 22.71M | 33.77M | 128.77M | 146.32M |
| Cash & Short-Term Investments | 192.11M | 59.05M | 70.33M | 83.37M | 96.66M | 110.76M | 76.67M | 18.63M | 19.25M | 29.88M | 125.61M | 142.68M |
| Cash Only | 192.11M | 59.05M | 70.33M | 83.37M | 96.66M | 110.76M | 60.69M | 18.63M | 19.25M | 29.88M | 11.74M | 9.08M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 15.98M | 0 | 0 | 0 | 113.88M | 133.6M |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.04M | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 5.38M | 1.79M | 1.2M | 1.18M | 1.51M | 0 | 331K | 656K | 739K | 0 | 3.16M | 3.64M |
| Total Non-Current Assets | 1.21M | 1.28M | 1.31M | 1.52M | 1.71M | 1.9M | 646K | 1.68M | 1.82M | 1.97M | 1.62M | 1.72M |
| Property, Plant & Equipment | 807K | 1M | 1.21M | 1.4M | 1.6M | 1.79M | 499K | 1.63M | 1.77M | 1.91M | 1.53M | 1.64M |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 405K | 273K | 104K | 116K | 109K | 109K | 147K | 49K | 51K | 58K | 81K | 79K |
| Total Assets | 198.69M | 62.12M | 72.83M | 86.07M | 99.88M | 114.91M | 77.64M | 25.47M | 24.53M | 35.73M | 130.39M | 148.04M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | 98.93% | -45.94% | -6.19% | 237.89% | 307.23% | 221.56% | -40.45% | -82.79% | - | - | - | - |
| Total Current Liabilities | 14.33M | 5.92M | 6.25M | 7.6M | 8.79M | 10.53M | 3.25M | 12.98M | 5.55M | 7.29M | 13.56M | 13.74M |
| Accounts Payable | 11.02M | 1.43M | 1.29M | 2.38M | 2.34M | 2.97M | 237K | 8.26M | 3.62M | 3.42M | 2.47M | 1.83M |
| Days Payables Outstanding | - | - | - | - | - | - | 32.58K | - | - | - | 4.6K | - |
| Short-Term Debt | 409K | 549K | 567K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 325K | 318K |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 2.9M | 3.94M | 4.39M | 2.1M | 1.38M | 3.17M | 2.36M | 1.71M | 587K | 1.66M | 6.93M | 9.07M |
| Current Ratio | 13.78x | 10.28x | 11.45x | 11.13x | 11.17x | 10.73x | 23.71x | 1.83x | 4.09x | 4.64x | 9.49x | 10.65x |
| Quick Ratio | 13.78x | 10.28x | 11.45x | 11.13x | 11.17x | 10.73x | 23.71x | 1.83x | 4.09x | 4.64x | 9.49x | 10.65x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 12K | 12K | 160K | 307K | 449K | 549K | 379K | 136.07M | 130.24M | 130.29M | 1.88M | 1.77M |
| Long-Term Debt | 0 | 0 | 120K | 0 | 0 | 0 | 0 | 5.86M | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 267K | 409K | 549K | 379K | 357K | 412K | 466K | 812K | 897K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 12K | 12K | 40K | 40K | 40K | 0 | 0 | 129.85M | 129.82M | 129.82M | 1.07M | 876K |
| Total Liabilities | 14.34M | 5.93M | 6.41M | 7.9M | 9.23M | 11.08M | 3.63M | 149.05M | 135.79M | 137.58M | 15.44M | 15.51M |
| Total Debt | 409K | 549K | 687K | 823K | 955K | 1.08M | 665K | 6.43M | 624K | 674K | 1.14M | 1.22M |
| Net Debt | -191.7M | -58.5M | -69.64M | -82.55M | -95.71M | -109.68M | -60.02M | -12.2M | -18.62M | -29.2M | -10.6M | -7.87M |
| Debt / Equity | 0.00x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | - | - | - | 0.01x | 0.01x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | 0.03x | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | -1.36x | - | - |
| Interest Coverage | - | -2249.50x | -7348.50x | - | - | - | - | -542.81x | - | - | - | - |
| Total Equity | 184.35M | 56.18M | 66.43M | 78.17M | 90.65M | 103.83M | 74.02M | -123.58M | -111.26M | -101.84M | 114.94M | 132.53M |
| Equity Growth % | 103.37% | -45.89% | -10.25% | 163.25% | 181.47% | 201.95% | -35.61% | -193.25% | - | - | - | - |
| Book Value per Share | 13.48 | 4.16 | 4.92 | 5.79 | 6.75 | 7.78 | 5.55 | -9.26 | -8.34 | -7.63 | 8.62 | 9.94 |
| Total Shareholders' Equity | 184.35M | 56.18M | 66.43M | 78.17M | 90.65M | 103.83M | 74.02M | -123.58M | -111.26M | -101.84M | 114.94M | 132.53M |
| Common Stock | 4K | 1K | 1K | 1K | 1K | 1K | 0 | 1K | 1K | 0 | 3K | 3K |
| Retained Earnings | -229.4M | -214.24M | -200.74M | -186.04M | -170.65M | -154.72M | -235.95M | -125.73M | -111.59M | -102.05M | -190.52M | -171.32M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 2K | 0 | 0 | 0 | -21K | -31K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |